Edition:
United States

People: PerkinElmer Inc (PKI)

PKI on New York Consolidated

50.99USD
2 Dec 2016
Change (% chg)

$0.25 (+0.49%)
Prev Close
$50.74
Open
$50.74
Day's High
$51.39
Day's Low
$50.51
Volume
470,951
Avg. Vol
598,713
52-wk High
$57.28
52-wk Low
$39.50

Corbett, James 

Mr. James Corbett is President of our Human Health business of the company in March 2014 and has been a Senior Vice President and officer of PerkinElmer since February 2012. Mr. Corbett was appointed President of the Diagnostics business in May 2010 and was appointed President of the Life Sciences and Technology business in May 2013. Mr. Corbett joined the Company in October of 2007 through our acquisition of ViaCord, where he served as President. Prior to joining ViaCord, he co-founded CADx Systems, a company focused on the oncology market, where he held the position of Executive Vice President and Director with responsibility for worldwide sales and marketing, technical support and business development. Following the 2004 acquisition of CADx by iCAD, Inc., he was named Chief Commercial Officer. In addition, Mr. Corbett worked for Abbott Laboratories for 14 years in a variety of sales and marketing positions including Worldwide Marketing Manager for Abbott Diagnostics Immunoassay Systems and Region Manager for Abbott Diagnostics. Mr. Corbett holds a Bachelor of Science degree in business from the University of Massachusetts. Mr. Corbett also serves on the national board of trustees for the March of Dimes Foundation.

Basic Compensation

Total Annual Compensation, USD 1,005,190
Restricted Stock Awards, USD 293,343
Long-Term Incentive Plans, USD --
All Other, USD 307,325
Fiscal Year Total, USD 1,605,860

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 75,252 1,777,930.00
Name Fiscal Year Total

Robert Friel

8,504,160

Frank Wilson

2,207,620

Joel Goldberg

1,843,720

James Corbett

1,605,860

Daniel Tereau

--

Andrew Okun

--
As Of  2 Jan 2016